DK1487466T3 - Anvendelse af Lactobacillus farcimins til forebyggelse eller behandling af fordöjelsespatologier - Google Patents

Anvendelse af Lactobacillus farcimins til forebyggelse eller behandling af fordöjelsespatologier

Info

Publication number
DK1487466T3
DK1487466T3 DK03725310T DK03725310T DK1487466T3 DK 1487466 T3 DK1487466 T3 DK 1487466T3 DK 03725310 T DK03725310 T DK 03725310T DK 03725310 T DK03725310 T DK 03725310T DK 1487466 T3 DK1487466 T3 DK 1487466T3
Authority
DK
Denmark
Prior art keywords
prevention
treatment
farcimins
lactobacillus
digestive pathologies
Prior art date
Application number
DK03725310T
Other languages
English (en)
Inventor
Jean Fioramonti
Lionel Bueno
Vassilia Theodorou
Florence Lamine
Original Assignee
Agronomique Inst Nat Rech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agronomique Inst Nat Rech filed Critical Agronomique Inst Nat Rech
Application granted granted Critical
Publication of DK1487466T3 publication Critical patent/DK1487466T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DK03725310T 2002-03-28 2003-03-21 Anvendelse af Lactobacillus farcimins til forebyggelse eller behandling af fordöjelsespatologier DK1487466T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0203891A FR2837711B1 (fr) 2002-03-28 2002-03-28 Utilisation de la lactobacillus farciminis pour la prevention ou le traitement de pathologies digestives
PCT/FR2003/000903 WO2003082307A1 (fr) 2002-03-28 2003-03-21 Utilisation de lactobacillus farciminis pour la prevention ou le traitement de pathologies digestives.

Publications (1)

Publication Number Publication Date
DK1487466T3 true DK1487466T3 (da) 2008-05-19

Family

ID=27839273

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03725310T DK1487466T3 (da) 2002-03-28 2003-03-21 Anvendelse af Lactobacillus farcimins til forebyggelse eller behandling af fordöjelsespatologier

Country Status (10)

Country Link
US (2) US7294337B2 (da)
EP (1) EP1487466B1 (da)
AT (1) ATE383163T1 (da)
AU (1) AU2003227852A1 (da)
CA (1) CA2480387C (da)
DE (1) DE60318558T2 (da)
DK (1) DK1487466T3 (da)
ES (1) ES2299698T3 (da)
FR (1) FR2837711B1 (da)
WO (1) WO2003082307A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1883451E (pt) * 2005-04-13 2011-03-02 Neuraxon Inc Compostos de indolo substituídos com actividade inibitória da sintetase de óxido nítrico (nos)
TW200808780A (en) * 2006-04-13 2008-02-16 Neuraxon Inc 1,5 and 3,6- substituted indole compounds having NOS inhibitory activity
FR2922450B1 (fr) * 2007-10-19 2014-06-13 Lallemand Sas Utilisation de bacteries lactique pour la prevention et/ou le traitement de pathologies cutanees
AU2008321353A1 (en) * 2007-11-16 2009-05-22 The Arizona Board Of Regents On Behalf Of The University Of Arizona Methods for treating visceral pain
WO2009062318A1 (en) * 2007-11-16 2009-05-22 Neuraxon, Inc. 3,5-substituted indole compounds having nos and norepinephrine reuptake inhibitory activity
WO2009062319A1 (en) * 2007-11-16 2009-05-22 Neuraxon, Inc. Indole compounds and methods for treating visceral pain
WO2009154463A2 (en) * 2008-06-20 2009-12-23 Stichting Top Institute Food And Nutrition Butyrate as a medicament to improve visceral perception in humans
US9107938B2 (en) 2010-09-30 2015-08-18 The Board Of Trustees Of The University Of Arkansas Methods of selecting and using therapeutic and prophylactic probiotic cultures to reduce bacterial pathogen loads
US20130017174A1 (en) * 2011-07-12 2013-01-17 The Board Of Trustees Of The University Of Arkansas Compositions and methods for increasing health and reducing pathogenic bacteria in animals
CN112804887A (zh) * 2018-09-26 2021-05-14 株式会社明治 线粒体功能改善剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2764802A1 (fr) * 1996-12-24 1998-12-24 Standa Lab Sa Composition adsorbable renfermant des bacteries propioniques susceptible de degager du monoxyde d'azote dans le tube digestif humain ou animal
AU2296897A (en) * 1997-03-20 1998-10-20 Jean James Garreau Food products based on soybean milk and method for making same
FR2785809B1 (fr) * 1998-11-18 2001-01-12 Gervais Danone Sa Selection et utilisations de souches de bacteries lactiques modulatrices de l'immunite non-specifique
US6849256B1 (en) * 1999-11-08 2005-02-01 Ganeden Biotech Incorporated Inhibition of pathogens by probiotic bacteria
EP1344458A1 (en) * 2002-03-12 2003-09-17 Société des Produits Nestlé S.A. Probiotic delivery system

Also Published As

Publication number Publication date
CA2480387A1 (fr) 2003-10-09
EP1487466B1 (fr) 2008-01-09
FR2837711A1 (fr) 2003-10-03
US20080085268A1 (en) 2008-04-10
US7628991B2 (en) 2009-12-08
US20050244389A1 (en) 2005-11-03
AU2003227852A1 (en) 2003-10-13
ES2299698T3 (es) 2008-06-01
US7294337B2 (en) 2007-11-13
DE60318558D1 (de) 2008-02-21
DE60318558T2 (de) 2009-01-22
WO2003082307A1 (fr) 2003-10-09
FR2837711B1 (fr) 2005-05-06
EP1487466A1 (fr) 2004-12-22
CA2480387C (fr) 2013-04-23
ATE383163T1 (de) 2008-01-15

Similar Documents

Publication Publication Date Title
EP3763830A4 (en) LACTOBACILLUS SP. NANOVESICLE BACTERIA DERIVED AND USES THEREOF
BRPI0511615A (pt) forma de administração oral compreendendo bactéria probiótica
EA200701918A1 (ru) Белок липокалин
DK1773361T3 (da) Sammensætning baseret på probiotiske bakterier og anvendelse deraf til forebyggelse og/eller behandling af respiratoriske sygdomme og/eller infektioner og til forbedring af en intestinale funktionalitet
DE602004011497D1 (de) Symbiotische zusammensetzung
DE60327438D1 (de) Amino-substituierte cyclohexan derivate zur behandlung bakterieller infektionen
RS52625B (en) FLUORO SUBSTITUTED OMEGA-CARBOXYARYL DIPHENYL UREA FOR TREATMENT AND PREVENTION OF DISEASES AND DISEASES
MY147247A (en) Organic compounds and their uses
WO2005112976A3 (en) Probiotic compounds from lactobacillus gg and uses therefor
DK1487466T3 (da) Anvendelse af Lactobacillus farcimins til forebyggelse eller behandling af fordöjelsespatologier
MX2008001597A (es) Formulaciones novedosas que comprenden fenofibrato y una estatina y metodos relacionados de tratamiento.
HK1100091A1 (en) Nitrite-oxidizing bacteria and methods of using and detecting the same
SE0400355D0 (sv) New synbiotec use
SG11202103103TA (en) Gdsl lipase, genetically-engineered bacteria and application thereof
DK1641436T3 (da) Inhalerbar aztreonamlysinatformulering til behandling af og forebyggelse mod bakterielle lungeinfektioner
EA200870584A1 (ru) Пролекарства пенема
EA200600404A1 (ru) Пероральные препаративные формы кладрибина
DK1353948T3 (da) Oplöselige biologiske analoge til bata-amyloidpeptid
IL288864A (en) Treatment that includes sglt inhibitors, for example sglt 1/2 inhibitors
ZA200610279B (en) Treatment of bacterial infections
UA85187C2 (en) 2-aminobenzoyl derivatives
MY141010A (en) Use of ppar agonists for the treatment of congestive heart failure
GB201911728D0 (en) Bacterial composistions for the treatment of disease
UA44858S (uk) 1. крісло
UA45375S (uk) 1. ортопедична подушка